期刊文献+

P-gp与癫耐药相关性研究进展 被引量:6

下载PDF
导出
摘要 P-gp是由ABCB1基因编码的能量依赖性跨膜外向转运蛋白,在灶组织内的表达明显增加,影响AEDs通过血脑屏障,降低灶组织内AEDs浓度。给予P-gp抑制剂,不仅可以提高耐药细胞内AEDs浓度,也能增加灶组织内AEDs浓度,并扭转癫的耐药性。越来越多的研究从P-gp的结构、功能和过表达等方面阐述与癫耐药的相关性,现就这一方面的研究进展作一综述。
作者 顾浩 张庆
出处 《中国实用神经疾病杂志》 2011年第4期89-92,共4页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献34

  • 1Duncan JS,Sander JW,Sisodiya SM,et al.Adult epilepsy[J].Lancet,2006,367(9516):1 087-1 100.
  • 2王文志,吴建中,王德生,陈桂生,王太平,袁成林,杨斌,赵东海.中国五省农村人群癫痫流行病学抽样调查[J].中华医学杂志,2002,82(7):449-452. 被引量:165
  • 3ILEA Commission report:the epidemiology of the epilepsies:future direction[J].Epilepsia,1997,38:614-618.
  • 4Schmidt D,Gram L.Monotherapy versus polytherapsy in epilepsy:a reappraisal[J].CNS Drugs,1995,3:194-208.
  • 5Regesta G,Tanganelli P.Clinical aspects and biological bases of drug-resistance.epilepsies[J].Epilepsy Res,1999,34(2):109-122.
  • 6Kim R,Leake B,Choo E,et al.Identification of functionally variant ABCB1 alleles among European Americans and African Americans[J].Clin Phamacol Ther,2001,70(2):189-199.
  • 7Ameyaw MM,Regateiro F,Li T,et al.ABCB1 pharmacogenetics:frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity[J].Pharmacogenetcis,2001,11(3):217-221.
  • 8Tang K,Ngoi S,Gwee P,et al.Distinct haplotype profiles and strong linkage disequilibrium at the ABCB1 multidrug transporter gene locus in three ethnic asia populations[J].Harmacogenetics,2002,12(6):437-445.
  • 9Chowbay B,Cumaraswamy S,Cheung YB,et al.Enetic polymorphisms in ABCB1 and CYP3A4 genes in Asians and the influence of ABCB1 haplotypes on cyclosporine disposition in heart transplant recipients[J].Pharmacogenetics,2003,13(2):89-95.
  • 10Hoffmeyer S,Burk O,von Richter O,et al.Functional polymorphisms of the human multidrug-resistance gene:multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo[J].Proc Natl Acad Sci,2000,97:3 473-3 478.

二级参考文献14

  • 1陈英辉,赵永波,马爱梅,王乃东,呙登俊.难治性癫痫患者脑内MDR1的表达[J].中风与神经疾病杂志,2006,23(1):60-60. 被引量:7
  • 2李世绰.中国六城市居民癫痫的流行病学调查[J].中华神经精神科杂志,1986,19(4):193-193.
  • 3Loscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther, 2002, 301(1): 7-14.
  • 4Potschka H, Baltes S, Loscher W. Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats. Epilepsy Res, 2004, 58 (2-3): 85-91.
  • 5Owen A, Pirmohamed M, Tettey J N, et al. Carbamazepine is not a substrate for P-glycoprotein. Br J Clin Pharmacol, 2001, 51 (4): 345-349.
  • 6Weiss J, Kerpen C J, Lindenmaier H, et al. Interaction of antiepileptic drugs with human P-glycoprotein in vitro. J Pharmacol Exp Ther, 2003, 307(1): 262-267.
  • 7Potschka H, Fedrowitz M, Loscher W. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR rats. Epilepsia, 2003, 44 (12): 1479-1486.
  • 8Aronica E, Gorter J A, Redeker S. Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia, 2005, 46(6): 849-857.
  • 9Awasthi S, Hallene K L, Fazio V. RL1P76, a non-ABC transporter, and drug resistance in epilepsy. BMC Nettrosci, 2005, 27(6): 61.
  • 10Sisodiya S M, Martinian L, Scheffer G L, et al. Vascular colocalization of P-glyeoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies. Neuropathol Appl Neurobiol, 2006, 32(1): 51-63.

共引文献167

同被引文献32

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部